These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30825056)

  • 1. Cause and effect of microenvironmental acidosis on bone metastases.
    Avnet S; Di Pompo G; Lemma S; Baldini N
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):133-147. PubMed ID: 30825056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidosis and proteolysis in the tumor microenvironment.
    Ji K; Mayernik L; Moin K; Sloane BF
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):103-112. PubMed ID: 31069574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Crosstalk between Metastatic Breast Cancer Cells and the Bone Microenvironment.
    Zarrer J; Haider MT; Smit DJ; Taipaleenmäki H
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32092997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA; Edwards JR; Martin TJ; Mundy GR
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
    Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
    Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.
    Siclari VA; Guise TA; Chirgwin JM
    Cancer Metastasis Rev; 2006 Dec; 25(4):621-33. PubMed ID: 17165131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain.
    Yoneda T; Hiasa M; Nagata Y; Okui T; White F
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2677-84. PubMed ID: 25687976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.
    Pluijm G; Löwik C; Papapoulos S
    Cancer Treat Rev; 2000 Feb; 26(1):11-27. PubMed ID: 10660489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
    Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
    Futakuchi M; Fukamachi K; Suzui M
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone metastases of breast cancer].
    Hata K; Yoneda T
    Clin Calcium; 2014 Aug; 24(8):1177-84. PubMed ID: 25065869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells.
    Simone V; Ciavarella S; Brunetti O; Savonarola A; Cives M; Tucci M; Opinto G; Maiorano E; Silvestris F
    BMC Cancer; 2015 Oct; 15():692. PubMed ID: 26468083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of bone metastases: causes and consequences.
    Harvey HA; Cream Lv
    Clin Breast Cancer; 2007 Jul; 7 Suppl 1():S7-S13. PubMed ID: 17683652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Metastasis of Breast Cancer.
    Tahara RK; Brewer TM; Theriault RL; Ueno NT
    Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
    Yoneda T; Hiraga T
    Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.
    Trinkaus M; Ooi WS; Amir E; Popovic S; Kalina M; Kahn H; Singh G; Gainford MC; Clemons M
    Oncol Rep; 2009 May; 21(5):1153-9. PubMed ID: 19360288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocytes and Bone Metastasis.
    Riquelme MA; Cardenas ER; Jiang JX
    Front Endocrinol (Lausanne); 2020; 11():567844. PubMed ID: 33162934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of breast cancer metastases to bone.
    Guise TA; Kozlow WM; Heras-Herzig A; Padalecki SS; Yin JJ; Chirgwin JM
    Clin Breast Cancer; 2005 Feb; 5 Suppl(2):S46-53. PubMed ID: 15807924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.